Search Results - "MAURER, L. H"

Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study by Maurer, L H, Herndon, 2nd, J E, Hollis, D R, Aisner, J, Carey, R W, Skarin, A T, Perry, M C, Eaton, W L, Zacharski, L L, Hammond, S, Green, M R

“…Studies by the Veterans Administration Cooperative Studies Program and Cancer and Leukemia Group B (CALGB) suggested that the addition of warfarin to…”
Get more information

Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B by Ahles, T A, Silberfarb, P M, Herndon, 2nd, J, Maurer, L H, Kornblith, A B, Aisner, J, Perry, M C, Eaton, W L, Zacharski, L L, Green, M R, Holland, J C

“…The current study assessed the psychologic and neuropsychologic functioning of patients with small-cell lung cancer who were randomized in a large clinical…”
Get more information

Estrogen plus progestin increase superoxide dismutase and total antioxidant capacity in postmenopausal women by Unfer, T. C., Figueiredo, C. G., Zanchi, M. M., Maurer, L. H., Kemerich, D. M., Duarte, M. M. F., Konopka, C. K., Emanuelli, T.

“…Abstract Objective This cross-sectional study aimed to evaluate the behavior of blood antioxidant enzymes (superoxide dismutase (SOD), catalase and glutathione…”
Get full text

Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients by Spiegelman, D, Maurer, L H, Ware, J H, Perry, M C, Chahinian, A P, Comis, R, Eaton, W, Zimmer, B, Green, M

“…Cancer and Leukemia Group B (CALGB) accrued 1,745 patients with limited (LD) or extensive (ED) small-cell lung cancer (SCCL) to five separate trials between…”
Get more information

Non-genomic, direct modulatory effect of 17β-estradiol, progesterone and their synthetic derivatives on the activity of human erythrocyte CuZn superoxide dismutase by Unfer, T C, Maurer, L H, Kemerich, D M, Figueiredo, C G, Duarte, M M F, Gelain, D P, Moreira, J C F, Emanuelli, T

“…This study aimed to evaluate whether natural or synthetic steroid hormones could directly modulate the activity of the different superoxide dismutase (SOD)…”
Get more information

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment by Nugent, MD, William C, Edney, BA, Mark T, Hammerness, BA, Paul G, Dain, PhD, Bradley J, Maurer, MD, L.Herbert, Rigas, MD, James R

“…Background. Early detection and surgical resection offers the highest likelihood of cure for patients with lung cancer. Patients presenting at the extremes of…”
Get full text

Socioeconomic status and cancer survival by Cella, D F, Orav, E J, Kornblith, A B, Holland, J C, Silberfarb, P M, Lee, K W, Comis, R L, Perry, M, Cooper, R, Maurer, L H

“…Survival data from eight Cancer and Leukemia Group B (CALGB) protocols were examined for patients with lung cancer (N = 961), multiple myeloma (N = 577),…”
Get more information

Clinical trials in a rural population: professional education aspects by Maurer, L H, Davis, T, Hammond, S, Smith, E, West, P, Doolittle, M

“…While the majority of cancer patients in rural New Hampshire and Vermont are treated in community hospitals, few have entered clinical trials. This report…”
Get more information

Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study by Aisner, J, Goutsou, M, Maurer, L H, Cooper, R, Chahinian, P, Carey, R, Skarin, A, Slawson, R, Perry, M C, Green, M R

“…In prior Cancer and Leukemia Group B (CALGB) studies, combined chemotherapy and thoracic irradiation was superior to chemotherapy alone in limited-disease (LD)…”
Get more information

Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests by Xue, F, Yu, H, Maurer, L H, Memoli, V A, Nutile-McMenemy, N, Schuster, M K, Bowden, D W, Mao, J, Noll, W W

“…Multiple endocrine neoplasia type 2A (MEN 2A) and familial medullary thyroid carcinoma (FMTC) are two closely related cancer syndromes inherited in an…”
Get more information

Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up by Lattanzi, S C, Tosteson, T, Chertoff, J, Maurer, L H, O'Donnell, J, LeMarbre, P J, Mott, L, DelPrete, S A, Forcier, R J, Ernstoff, M S

“…Metastatic melanoma has a grim prognosis. Response rates and survival of patients treated with combination chemotherapy are not superior to single-agent…”
Get more information

Continuous intratumoral infusion of methotrexate for recurrent glioblastoma: a pilot study by Nierenberg, D, Harbaugh, R, Maurer, L H, Reeder, T, Scott, G, Fratkin, J, Newman, E

“…Five patients with documented recurrences of glioblastoma multiforme were given continuous infusions of methotrexate delivered intratumorally using implantable…”
Get more information

Outcomes and complications of continuous intraspinal narcotic analgesia for cancer pain control by Coombs, D W, Maurer, L H, Saunders, R L, Gaylor, M

“…Preliminary reports of continuous intraspinal morphine analgesia have been enthusiastic regarding the resultant cancer pain control. Reports of continuous…”
Get more information

The relationship of psychological distress, extent of disease, and performance status in patients with lung cancer by Cella, D F, Orofiamma, B, Holland, J C, Silberfarb, P M, Tross, S, Feldstein, M, Perry, M, Maurer, L H, Comis, R, Orav, E J

“…This study examined the association between two primary covariates, extent of disease (ED) and performance status rating (PSR), and the outcome of…”
Get more information

Studies of possible mechanisms for the effect of urokinase therapy in small cell carcinoma of the lung by Meehan, K R, Zacharski, L R, Maurer, L H, Howell, A L, Memoli, V A, Rousseau, S M, Hunt, J A, Henkin, J

“…Urokinase-type plasminogen activator has been administered by other investigators to patients with small cell carcinoma of the lung (SCCL) in an attempt to…”
Get more information

Phase II trial of tamoxifen, etoposide, mitoxantrone, and cisplatin in patients with metastatic breast carcinoma by Conzen, Suzanne D., Kaufman, Peter A., Arvizu, Christine, LeMarbre, Paul, Maurer, L. Herbert, Mott, Leila A., Mills, Letha E.

“…BACKGROUND Based on previous data demonstrating a potentially synergistic interaction between tamoxifen and cisplatin in metastatic melanoma therapy, a Phase…”
Get full text

Characterization and quantification of tannins, flavonols, anthocyanins and matrix-bound polyphenols from jaboticaba fruit peel: A comparison between Myrciaria trunciflora and M. jaboticaba by Quatrin, A., Pauletto, R., Maurer, L.H., Minuzzi, N, Nichelle, S.M., Carvalho, J.F.C., Maróstica, M.R., Rodrigues, E., Bochi, V.C., Emanuelli, T.

“…[Display omitted] •New ellagitannins, gallotannins and flavonols are reported in jaboticaba peel (JPP).•Matrix-bound polyphenols ranges from 4 to 21% depending…”
Get full text

Hormone production by cultures of small-cell carcinoma of the lung by Sorenson, G D, Pettengill, O S, Brinck-Johnsen, T, Cate, C C, Maurer, L H

“…Continuous cell lines have been established from a variety of biopsy and postmortem species of tumor from patients with small-cell carcinoma of the lung (SCCL)…”
Get more information

Combined modality therapy with radiotherapy, chemotherapy, and immunotherapy in limited small-cell carcinoma of the lung: a Phase III cancer and Leukemia Group B Study by Maurer, L H, Pajak, T, Eaton, W, Comis, R, Chahinian, P, Faulkner, C, Silberfarb, P M, Henderson, E, Rege, V B, Baldwin, P E

“…Patients with limited-stage small-cell carcinoma of the lung (SCCL) were randomly assigned to a four-drug chemotherapy program consisting of methotrexate,…”
Get more information

A phase I/II trial of etoposide and cisplatin in extensive small cell lung cancer : A Cancer and Leukemia Group B study by MITCHELL, E. P, PERRY, M. C, LUIKART, S. D, CIRRINCIONE, C. T, VAN ECHO, D. A, HERNDON, J. E, MAURER, L. H, CLAMON, G, GREEN, M. R

“…Patients with untreated extensive small cell lung cancer (SCLC) with CALGB performance scores 0-2 were treated with etoposide 200 mg/m2/day on days 1-3 and…”
Get full text